DE69927044D1 - Verfahren zur racemizierung - Google Patents

Verfahren zur racemizierung

Info

Publication number
DE69927044D1
DE69927044D1 DE69927044T DE69927044T DE69927044D1 DE 69927044 D1 DE69927044 D1 DE 69927044D1 DE 69927044 T DE69927044 T DE 69927044T DE 69927044 T DE69927044 T DE 69927044T DE 69927044 D1 DE69927044 D1 DE 69927044D1
Authority
DE
Germany
Prior art keywords
general formula
vii
compounds
racemication
halogenophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927044T
Other languages
English (en)
Other versions
DE69927044T2 (de
Inventor
Maria Bakonyi
Tiborne Bai
Zsolt Dombrady
Katalin Gaspar
Attila Supic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of DE69927044D1 publication Critical patent/DE69927044D1/de
Application granted granted Critical
Publication of DE69927044T2 publication Critical patent/DE69927044T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Glass Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Processing Of Stones Or Stones Resemblance Materials (AREA)
DE69927044T 1998-11-09 1999-11-05 Verfahren zur racemizierung Expired - Lifetime DE69927044T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9802586 1998-11-09
HU9802586A HU226421B1 (en) 1998-11-09 1998-11-09 Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
PCT/HU1999/000076 WO2000027840A1 (en) 1998-11-09 1999-11-05 Process for racemization

Publications (2)

Publication Number Publication Date
DE69927044D1 true DE69927044D1 (de) 2005-10-06
DE69927044T2 DE69927044T2 (de) 2006-06-22

Family

ID=89997319

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927044T Expired - Lifetime DE69927044T2 (de) 1998-11-09 1999-11-05 Verfahren zur racemizierung

Country Status (12)

Country Link
US (2) US6670486B1 (de)
EP (1) EP1129087B1 (de)
JP (1) JP4598276B2 (de)
AT (1) ATE303377T1 (de)
AU (1) AU1289600A (de)
BR (1) BR9914883A (de)
CA (1) CA2347853C (de)
DE (1) DE69927044T2 (de)
DK (1) DK1129087T3 (de)
ES (1) ES2249038T3 (de)
HU (1) HU226421B1 (de)
WO (1) WO2000027840A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
EP1606231A1 (de) * 2003-02-03 2005-12-21 Nadkarni, Sunil Sadanand Verfahren zur herstellung von clopidogrel, seine salze und pharmazeutische zusammensetzungen
WO2004108665A2 (en) * 2003-04-24 2004-12-16 Sun Pharmaceutical Industries Limited A process for preparation of clopidogrel
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
FR2916441B1 (fr) * 2007-05-22 2009-08-28 Clariant Specialty Fine Chem Procede de racemisation d'alpha-aminoacetals optiquement actifs.
EP2319926B1 (de) 2007-07-05 2016-08-31 Arrowhead Research Corporation DSRNA zur Behandlung viraler Infektionen
FR2927900B1 (fr) * 2008-02-27 2010-09-17 Clariant Specialty Fine Chem Procede de preparation d'alpha-aminoacetals optiquement actifs.
EP2346879A1 (de) * 2008-10-24 2011-07-27 Sandoz AG Verfahren zur herstellung von s-clopidogrel
CN110627808B (zh) * 2018-06-21 2022-04-01 江苏同禾药业有限公司 一种硫酸氢氯吡格雷拆分母液的回收处理工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632646A (en) * 1967-05-25 1972-01-04 Uniroyal Inc Succinamides
HU178455B (en) * 1979-07-17 1982-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 1-substituted-3-cycloalkyl-sulfonyl-pyrrolidine-2,5-dione derivatives
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
NL8501093A (nl) * 1985-04-12 1986-11-03 Stamicarbon Werkwijze voor het racemiseren van een optisch aktief n- benzylideenaminozuuramide.
JPS62252751A (ja) * 1986-04-25 1987-11-04 Nitto Chem Ind Co Ltd α−アミノ酸アミドのラセミ化法
JPH0780823B2 (ja) * 1986-08-26 1995-08-30 東ソー株式会社 光学活性フェニルアラニンのラセミ化方法
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
HU225504B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them
HU222283B1 (hu) 1997-05-13 2003-05-28 Sanofi-Synthelabo Eljárás tieno[3,2-c]piridin-származékok előállítására
HU225503B1 (en) * 1997-05-13 2007-01-29 Sanofi Aventis Novel 2-(2-halophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides and process for producing them

Also Published As

Publication number Publication date
DE69927044T2 (de) 2006-06-22
US20040106824A1 (en) 2004-06-03
US7109356B2 (en) 2006-09-19
AU1289600A (en) 2000-05-29
JP4598276B2 (ja) 2010-12-15
HU9802586D0 (en) 1999-01-28
ES2249038T3 (es) 2006-03-16
CA2347853A1 (en) 2000-05-18
HUP9802586A3 (en) 2001-05-28
HU226421B1 (en) 2008-12-29
EP1129087B1 (de) 2005-08-31
JP2002529462A (ja) 2002-09-10
CA2347853C (en) 2009-08-18
ATE303377T1 (de) 2005-09-15
BR9914883A (pt) 2001-07-17
EP1129087A1 (de) 2001-09-05
WO2000027840A1 (en) 2000-05-18
HUP9802586A2 (hu) 2001-04-28
US6670486B1 (en) 2003-12-30
DK1129087T3 (da) 2006-01-16

Similar Documents

Publication Publication Date Title
DE69927044D1 (de) Verfahren zur racemizierung
EA199700124A1 (ru) Производные гуанина
DE60012268D1 (de) Verfahren zum Herstellen von Acrylsäure
DE60110497D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60128429D1 (de) Verfahren zur kontiuierlichen Herstellung von optischen Gegenständen
ATE319702T1 (de) Verfahren zur herstellung von benzothiophen- derivaten
DE04010770T1 (de) Verfahren zur Rückgewinnung von Statinverbindungen aus einer Fermentationsbrühe
DE60005870D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60038560D1 (de) Verfahren zur fermentativen Herstellung von L-Arginin
HUP9901526A2 (hu) Atorvastatin szintézis, közbenső termékei és eljárás ezek előállítására
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
EA200300520A1 (ru) Способ получения кристаллического моногидрата n-формимидоилтиенамицина (моногидрата имипенема)
BR0208999A (pt) Processo para a preparação de ácido de cefpodoxima
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
ITMI20002187A0 (it) Processo per la produzione dell'acido r(+) -lipico
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
DE60012802D1 (de) Verfahren zur Herstellung von optisch aktiven Cyanhydrinen
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60220157D1 (de) Verfahren zur modulierung der proliferation von medullären schilddrüsen-karzinomzellen
ATE282589T1 (de) Verfahren zur herstellung eines chiralen-beta- aminosäureesters
EA200001153A1 (ru) Очистка карбоксальдегида
DE69833365D1 (de) Verfahren zur herstellung optisch aktiver amine
DK0965586T3 (da) Fremgangsmåde til oprensning af carbazolesterforstadier til 6-chlor-alfa-methyl-carbazol-2-eddikesyre
BRPI0413686A (pt) processo para a preparação ésteres dialquìlicos de ácido alfa-fluormalÈnico
DE69913517D1 (de) Verfahren zur herstellung einer kristallsuspensionhenonen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

R082 Change of representative

Ref document number: 1129087

Country of ref document: EP

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, DE